Compliance

  • January 07, 2026

    Poultry Cos. Seek Stay Of Water Pollution Ruling For Appeal

    Tyson Foods and other poultry operators found responsible for polluting Oklahoma waters with chicken waste argued that, without a stay in the court's judgment pending a Tenth Circuit appeal, companies not subject to its orders will have an economic advantage.

  • January 07, 2026

    NLRB Gets Up To Speed As Members And GC Are Sworn In

    The National Labor Relations Board is set to resume deciding cases after two new members arrived at the agency Wednesday along with President Donald Trump's pick to lead the Office of the General Counsel.

  • January 07, 2026

    Ørsted Expands Challenge To Halt Of Offshore Wind Projects

    Danish energy developer Ørsted has expanded its legal fight against the Trump administration's latest order halting offshore wind projects, filing a lawsuit claiming the order unlawfully blocks the construction of its Sunrise Wind project off the New York coast.

  • January 07, 2026

    Ind. Bill Seeks Uniform Assessments Regardless Of Owner

    Indiana would require that all tangible property and agricultural land be assessed in a uniform manner regardless of the owner under a bill introduced in the state House of Representatives.

  • January 07, 2026

    Compass' $1.6B Anywhere Buy Goes Unchallenged By Government

    Real estate brokerage Compass Inc.'s $1.6 billion acquisition of Anywhere Real Estate Inc. is expected to move forward Wednesday without being scrutinized by the federal government even though congressional lawmakers previously urged the government to do so.

  • January 06, 2026

    Texas Court Reverses Halt On Samsung's TV Data Collection

    A Texas state judge Tuesday lifted his temporary block on Samsung deploying technology that the state's attorney general has alleged the television maker is using to unlawfully spy on viewers and harvest their data.

  • January 06, 2026

    5th Circ. Pushes FDA On 'De Facto' Vape Marketing Ban

    A Fifth Circuit panel seemed leery of the U.S. Food and Drug Administration's claim that it had no de facto ban in place for flavored refillable e-cigarette products, saying Tuesday that denying hundreds of thousands of applications seemed an awful lot like a ban.

  • January 06, 2026

    Ex-EEOC Officials Decry Harassment Guidance Rollback

    A group of former top officials at the Equal Employment Opportunity Commission and U.S. Department of Labor on Tuesday issued a statement criticizing the Trump administration's proposed elimination of guidance on workplace harassment, saying it's an attack on the LGBTQ community and strays from U.S. Supreme Court precedent.

  • January 06, 2026

    Amazon Nears Deal With Flex Drivers In Tip Skimming Suit

    Amazon and a group of Flex delivery drivers told a Seattle federal judge Tuesday they've reached an agreement in principle to resolve a 2021 putative class action accusing the e-commerce giant of withholding tips, prompting the court to pause the case pending a final settlement.

  • January 06, 2026

    Feds Sue Calif. Cities To Extinguish Natural Gas Bans

    The Trump administration is going after two cities in California over building codes that ban natural gas infrastructure in newly constructed buildings, alleging in a lawsuit Monday that these local rules "impose crushing costs" on Californians and run afoul of federal law.

  • January 06, 2026

    Judge Hints Conn. Dentist's Press Release Claims Lack Teeth

    A Connecticut appellate judge seemed to doubt Tuesday that a dentist had asserted clear constitutional claims against state officials who issued a press release about his $300,000 False Claims Act settlement, suggesting the case might actually sound in defamation.

  • January 06, 2026

    Law Clerk Conflict Talk Can't Get Javice Retrial, Feds Say

    Charlie Javice, the founder of defunct student loan startup Frank, should not get a new trial over charges that she defrauded JPMorgan, which acquired her company, simply because two clerks who worked on the trial had accepted offers from a law firm involved in the litigation, federal prosecutors have argued.

  • January 06, 2026

    US Removal Of Maduro Won't Curb Energy Cos.' Caution

    U.S. oil and gas companies will need significant legal and regulatory assurances that any new investment in Venezuela will be shielded from political instability before heeding President Donald Trump's call to fortify the country's floundering oil and gas industry.

  • January 06, 2026

    'Get Over' Yourself, Ho Says To Judges' Independence Worry

    U.S. Circuit Judge James C. Ho snapped back at colleagues on the bench who have raised the alarm over threats to judicial independence, writing in an article that those complaining judges "need to get over themselves" and stop bowing to the "cultural elites" who oppose the Trump administration.

  • January 06, 2026

    FTC Signals Support Of Miss. Bill For Midwives' Solo Practice

    A Federal Trade Commission official on Monday encouraged a Mississippi lawmaker to keep in mind the possible motives of opponents of proposed legislation that would exempt midwives from having to contract with physicians to provide advanced-level nursing care.

  • January 06, 2026

    FDA To Ease Regulation Of Wearables, Decision Software

    U.S. Food and Drug Administration Commissioner Marty Makary touted new federal guidance on Tuesday that he said would promote innovation by making it easier to bring certain kinds of wearable devices and clinical-decision software to market without a strict regulatory review.

  • January 06, 2026

    Wilcox Asks DC Circ. To Protect NLRB's Independence

    The D.C. Circuit should reverse a decision by two of its judges that would end the National Labor Relations Board's independence if allowed to stand, former board member Gwynne Wilcox argued, seeking to nix a ruling that lets President Donald Trump remove and replace NLRB members at will.

  • January 06, 2026

    GAO IDs 4 Funding Programs As Lacking Fraud Controls

    The U.S. Government Accountability Office has identified four federal agency funding programs as having failed to incorporate certain key requirements and leading practices meant to oversee and prevent fraud, waste and abuse in awards. 

  • January 06, 2026

    Ex-CFTC Chair, Robinhood's Top Atty Join FINRA Board

    Former U.S. Commodity Futures Trading Commission Chair Rostin Behnam and the chief legal officer for popular trading app Robinhood Markets are among those whose appointment to the board of Financial Industry Regulatory Authority was announced on Tuesday.

  • January 06, 2026

    BofA Faces Customer Suit Over Post-Jan. 6 'Surveillance'

    Bank of America was hit with a putative class action accusing it of financial privacy violations tied to the aftermath of the Jan. 6, 2021, U.S. Capitol attack, alleging the bank aggressively mined and illegally shared customer data with authorities looking for leads.

  • January 06, 2026

    Cider-Maker Challenges Federal Ban On Vintage Labeling

    A Washington state maker of alcoholic beverages is challenging a federal government restriction that prevents producers of cider, mead and wines made from any fruit besides grapes from including vintage years on their product labels, arguing that the policy withholds information from consumers and violates the First Amendment.

  • January 06, 2026

    Coupang Brass Face Suit Over Alleged Cybersecurity Failures

    The top brass of e-commerce company Coupang Inc. have been sued in California federal court by a shareholder who claims the company's executives and directors failed to maintain adequate cybersecurity protocols, leading to a data breach that exposed the personal information of millions of customers.

  • January 06, 2026

    NC Sheriff Faces Ouster Bid Over Alleged Threats To Lawmaker

    A district attorney in North Carolina has asked the State Bureau of Investigation to look into allegations of bribery and extortion against an elected county sheriff accused of trying to influence a state lawmaker's vote on an immigration bill.

  • January 06, 2026

    RFK Jr. Can't Avoid Medical Groups' Challenge To Vax Policy

    A Boston federal judge on Tuesday rebuffed U.S. Health and Human Services Secretary Robert F. Kennedy Jr.'s bid to dismiss a challenge to vaccine policy changes, saying medical associations have plausibly alleged a federal vaccine committee is not fairly balanced.

  • January 06, 2026

    Public Health Atty Talks Botulism, Infants And FDA Staffing

    Three years ago, a bacterial outbreak at a Michigan manufacturing plant sparked a shutdown and a national infant formula shortage. Another episode last year at a formula plant in Iowa should be a red flag for the public and a short-handed FDA, according to Sarah Sorscher of the Center for Science in the Public Interest.

Expert Analysis

  • Key Strategies For Supplement Cos. Facing Lead Risks

    Author Photo

    In the wake of a recent Consumer Reports article detailing dangerously high levels of lead in many popular protein powders, supplement companies face increased litigation, rising enforcement risks and reputational harm — underscoring the need to monitor supply chains, test ingredients and understand labeling standards, say attorneys at Husch Blackwell.

  • How AI Tech Suppliers Can Address IP Lawyers' Concerns

    Author Photo

    While artificial intelligence tools can help intellectual property lawyers be more productive and effective, AI tech providers must address issues of privilege, data privacy and confidentiality to make their technology viable and useful for IP law, say Tom Colson at Colson Law and Kevin Bronson at Simpson & Simpson.

  • From Bank Loans To Private Credit: Tips For Making The Shift

    Author Photo

    The relationship between private credit and syndicated bank deals will evolve as the private market continues to grow, introducing new challenges for borrowers comparing financing options, particularly pertaining to loan documentation and working capital, say attorneys at Haynes Boone.

  • 3 Takeaways From FDA Cell And Gene Therapy Draft Guidance

    Author Photo

    The U.S. Food and Drug Administration recently published draft guidance documents that sketch the clearest picture yet of the evolving regulatory framework for cell and gene therapies, reflecting an agency that is increasingly comfortable with flexible, science-driven approaches that extend beyond clinical trial models, say attorneys at MoFo.

  • Wells Process Reforms Serve SEC Chair's Transparency Goals

    Author Photo

    Enforcement policy changes U.S. Securities and Exchange Commission Chairman Paul Atkins recently set forth will help fulfill his stated goal of making Division of Enforcement investigations more fair and transparent by changing the Wells process to provide recipients earlier consultations with SEC staff, greater evidence access and more time to file responses, say attorneys at Dechert.

  • The Ins And Outs Of Decentralized Digital Asset Exchanges

    Author Photo

    As decentralized digital asset exchanges lack intermediaries, and so remain susceptible to fraud and market manipulation, ​​​​​​​an understanding of their design is crucial to help market participants avoid fraudulent practices such as liquidity rug pulls, says Swati Kanoria at Charles River.

  • Contradictory Rulings Show Complexity Of Swaps Regulation

    Author Photo

    Recent divergent rulings, including two by the same Nevada judge, on whether the Commodity Exchange Act preempts state gambling laws when applied to event contracts traded on U.S. Commodity Futures Trading Commission-regulated markets illustrate the uncertainty regarding the legality of prediction markets, say attorneys at Akin.

  • How New Law Transforms Large-Load Power Projects In Texas

    Author Photo

    S.B. 6 — the new Texas law that revises state regulations for large electrical loads and related behind-the-meter projects — introduces higher up-front costs for developers and more flexible operating models for large-load customers, but should provide the certainty needed for greater investment in generation, say attorneys at Sidley.

  • How Cos. Should Prepare For Prop 65 Listing Of Bisphenols

    Author Photo

    California regulators are moving toward classifying all p,p'-bisphenol chemicals as causing reproductive toxicity under Proposition 65, which could require warning notices for a vast range of consumer and industrial products, and open the floodgates to private litigation — so companies should proactively review their suppy chains, says Gregory Berlin at Alston & Bird.

  • Rule Amendments Pave Path For A Privilege Claim 'Offensive'

    Author Photo

    Litigators should consider leveraging forthcoming amendments to the Federal Rules of Civil Procedure, which will require early negotiations of privilege-related discovery claims, by taking an offensive posture toward privilege logs at the outset of discovery, says David Ben-Meir at Ben-Meir Law.

  • Series

    My Miniature Livestock Farm Makes Me A Better Lawyer

    Author Photo

    Raising miniature livestock on my farm, where I am fully present with the animals, is an almost meditative time that allows me to return to work invigorated, ready to juggle numerous responsibilities and motivated to tackle hard issues in new ways, says Ted Kobus at BakerHostetler.

  • When Mortgage Data Can't Prove Discriminatory Lending

    Author Photo

    As plaintiffs continue to use Home Mortgage Disclosure Act data as grounds for class actions, attorneys must consider the limits of a statistics-only approach and the need for manual loan file review to confirm indications of potential discriminatory lending, say Abe Chernin, Shane Oka and Kevin Oswald at Cornerstone Research.

  • NLRB Memo Shifts Tone On Defenses Against Union 'Salting'

    Author Photo

    The current Starbucks strike demonstrates the potential effects of salting, in which applicants seek employment in order to organize a union, and recent guidance from the National Labor Relations Board suggests that previously rejected employer defenses may now gain traction, says Daniel Johns at Cozen O'Connor.

  • Evaluating Nasdaq Tokenization Rule's Potential Impact

    Author Photo

    Nasdaq's recently proposed rule would enable settlement of tokenized equity securities and exchange-traded products using blockchain technology, which could lead to dramatic improvements in market efficiency, settlement speed and market access, but prudent skepticism about timelines and implementation capabilities is warranted, says James Brady at Katten.

  • FDA Biosimilar Guidance Should Ease Biologics Development

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration, indicating that the agency may no longer routinely require comparative efficacy studies when other evidence provides sufficient assurance of biosimilarity, underscores the FDA's trust in analytical technology as a driver of biologics access, say attorneys at Hogan Lovells.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Compliance archive.